Cost-effectiveness Analyses of 3 Kinds of Traditional Chinese Medicinal Injections in the Treatment of Coronary Heart Disease-induced Angina Pectoris Caused
GU Xiu-yan
Abstract
GU Xiu-yan
Abstract
OBJECTIVE:To evaluate the cost-effectiveness of 3 kinds of traditional Chinese medicinal injections in the treatment of angina pectoris caused by coronary heart disease(CHD).METHODS:223 CHD patients with angina pectoris were divided into 3 groups:group A(Xuesaitong injection),group B(Breviscapine for injection) and group C(Shuxuening injection). The curative effects were observed and the cost-effectiveness analyses of the 3 groups were conducted as well.RESULTS:The costs for the 3 groups were 1 345.50 yuan,1 768.125 yuan,1 770.00 yuan,respectively; the total effective rates were 83.75%,82.09% and 85.53%,respectively; the cost-effectiveness ratios were 16.07,21.54 and 20.69,respectively;the incremental cost-effectiveness ratios of group B and C were 254.60 and 238.48,respectively as against group A. CONCLUSION:Xuesaitong injection(group A) is the preferred therapy for angina pectoris caused by CHD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To evaluate the cost-effectiveness of 3 kinds of traditional Chinese medicinal injections in the treatment of angina pectoris caused by coronary heart disease(CHD).METHODS:223 CHD patients with angina pectoris were divided into 3 groups:group A(Xuesaitong injection),group B(Breviscapine for injection) and group C(Shuxuening injection). The curative effects were observed and the cost-effectiveness analyses of the 3 groups were conducted as well.RESULTS:The costs for the 3 groups were 1 345.50 yuan,1 768.125 yuan,1 770.00 yuan,respectively; the total effective rates were 83.75%,82.09% and 85.53%,respectively; the cost-effectiveness ratios were 16.07,21.54 and 20.69,respectively;the incremental cost-effectiveness ratios of group B and C were 254.60 and 238.48,respectively as against group A. CONCLUSION:Xuesaitong injection(group A) is the preferred therapy for angina pectoris caused by CHD.
Key concepts: Medicine, Angina, Coronary heart disease, Cost effectiveness, Coronary disease, Internal medicine, Cardiology, Traditional medicine